Discriminative stimulus functions of methanandamide and Δ9-THC in rats: Tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol

Psychopharmacology

Volumn 208, Issue 1, 2010, Pages 87-98

  Järbe, Torbjörn U C ^a,c   Li, Chen ^b   Vadivel, Subramanian K ^c   Makriyannis, Alexandros ^c  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

9 THC; AM678; Aminoalkylindoles; Drug discrimination; R (+) Methanandamide; Rats; Rimonabant; WIN55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ALCOHOL; AM 678; CANNABINOID 1 RECEPTOR; DRONABINOL; INDOLE DERIVATIVE; METHANANDAMIDE; NAPHTHALEN 1 YL (1 PENTYL 1H INDOL 3 YL)METHANONE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISCRIMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STIMULUS;

ANIMALS; ARACHIDONIC ACIDS; BENZOXAZINES; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; INDOLES; MALE; MORPHOLINES; NAPHTHALENES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; TETRAHYDROCANNABINOL;

EID: 72649092512     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1708-z     Document Type: Article

References (54)

1. V Abadji S Lin G Taha G Griffin LA Stevenson RG Pertwee A Makriyannis 1994 (R)-Methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability J Med Chem 37 1889 1893 10.1021/jm00038a020 1:CAS:528:DyaK2cXltlekt7g%3D 8021930 (Pubitemid 24219781)
2. 9-tetrahydrocannabinol: complete generalization with methanandamide Pharmacol Biochem Behav 79 431 437 10.1016/j.pbb.2004.08.020 1:CAS:528:DC%2BD2cXhtVCltbvM 15582014 (Pubitemid 39576160)
3. BS Basavarajappa BL Hungund 2005 Role of the endocannabinoid system in the development of tolerance to alcohol Alcohol Alcohol 40 15 24 1:CAS:528:DC%2BD2MXisVWjsw%3D%3D 15550443
4. J Bergman CP France SG Holtzman JL Katz W Koek DN Stephens 2000 Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands Psychopharmacology (Berl) 153 67 84 10.1007/s002130000567 1:CAS:528:DC%2BD3MXhtlGis7c%3D (Pubitemid 32127905)
5. AJ Brown 2007 Novel cannabinoid receptors Br J Pharmacol 152 567 575 10.1038/sj.bjp.0707481 1:CAS:528:DC%2BD2sXht1ejt7%2FN 17906678 (Pubitemid 350041541)
6. OFA Bueno EA Carlini E Finkelfarb J Suzuki 1976 Delta-9- tetrahydrocannabinol, ethanol and amphetamine as discriminative stimuli-generalization tests with other drugs Psychopharmacologia 46 235 243 10.1007/BF00421108 1:CAS:528:DyaE28Xkt1ylsL8%3D 951459
7. RT Burkey JR Nation 1997 (R)-Methanandamide, but not anandamide, generalizes to Δ9-THC in a drug-discrimination procedure Exp Clin Psychopharm 5 195 202 10.1037/1064-1297.5.3.195 1:CAS:528:DyaK2sXlsVyisLs%3D (Pubitemid 27346444)
8. 9-tetrahydrocannabinol J Pharmacol Exp Ther 263 118 1126
9. J De Vry KR Jentzsch 2002 Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist Eur J Pharmacol 457 147 152 10.1016/S0014-2999(02)02697-3 12464360 (Pubitemid 35447656)
10. J De Vry KR Jentzsch 2004 Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat Eur J Pharmacol 505 127 133 10.1016/j.ejphar.2004.10.012 15556145 (Pubitemid 39535684)
11. V Di Marzo T Bisogno L De Petrocellis I Brandi RG Jefferson RL Winckler JB Davis O Dasse A Mahadevan RK Razdan BR Martin 2001 Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands Biochem Biophys Res Commun 281 444 451 10.1006/bbrc.2001.4354 11181068 (Pubitemid 32928176)
12. K Extance AJ Goudie 1981 Inter-animal olfactory cues in operant drug discrimination procedures in rats Psychopharmacology (Berl) 73 363 371 10.1007/BF00426467 1:CAS:528:DyaL3MXktFOrurk%3D (Pubitemid 11114123)
13. T Georgieva S Devanathan D Stropova CK Park Z Salamon G Tollin VJ Hruby WR Roeske HI Yamamura E Varga 2008 Unique agonist-bound cannabinoid CB(1) receptor conformations indicate agonist specificity in signaling Eur J Pharmacol 581 19 29 10.1016/j.ejphar.2007.11.053 1:CAS:528:DC%2BD1cXhsVCms70%3D 18162180
14. M Glass JK Northup 1999 Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors Mol Pharmacol 56 1362 1369 1:CAS:528:DyaK1MXns1yhurg%3D 10570066
15. AC Howlett 2004 Efficacy in CB1 receptor-mediated signal transduction Br J Pharmacol 142 1209 1218 10.1038/sj.bjp.0705881 1:CAS:528:DC%2BD2cXntlCrsbY%3D 15308578 (Pubitemid 39178873)
16. JW Huffman R Mabon MJ Wu J Lu R Hart DP Hurst PH Reggio JL Wiley BR Martin 2003 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor Bioorg Med Chem 11 539 549 10.1016/S0968-0896(02)00451-0 1:CAS:528: DC%2BD3sXlt1Oksg%3D%3D 12538019 (Pubitemid 36132231)
17. TUC Järbe 1977 Alcohol discrimination in gerbils: Interactions with bemegride, DH-524, d-amphetamine, and delta-9-THC Arch Int Pharmacodyn Ther 227 118 129 901060
18. 9-THC training dose as a determinant for (R)-methanandamide generalization in rats Psychopharmacology (Berl) 140 519 522 10.1007/s002130050797 (Pubitemid 28566852)
19. TUC Järbe RJ Lamb S Lin A Makriyannis 2000 Δ9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication Behav Pharmacol 11 81 86 10821212
20. 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide Psychopharmacology (Berl) 156 369 380 10.1007/s002130100730 (Pubitemid 32695845)
21. TUC Järbe NV DiPatrizio C Li A Makriyannis 2003 The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats Pharmacol Biochem Behav 75 809 821 10.1016/S0091-3057(03)00168-0 12957223 (Pubitemid 37289466)
22. 9-THC induced operant rate decreases in rats are not readily antagonized by SR-141716A Eur J Pharmacol 466 121 127 10.1016/S0014-2999(03) 01491-2 12679148 (Pubitemid 36385097)
23. TUC Järbe MY Harris C Li Q Liu A Makriyannis 2004 Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist Psychopharmacology (Berl) 177 35 45 10.1007/s00213-004-1916-5 (Pubitemid 40109912)
24. TUC Järbe RJ Lamb Q Liu A Makriyannis 2006 Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Δ9-THC or (R)-methanandamide (AM-356) Psychopharmacology (Berl) 188 315 323 10.1007/s00213-006-0517-x (Pubitemid 44387459)
25. 9-THC and (R)-methanandamide in rats Psychopharmacology (Berl) 184 36 45 10.1007/s00213-005-0225-y (Pubitemid 43005755)
26. TUC Järbe C Li SK Vadivel A Makriyannis 2008 Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats Psychopharmacology (Berl) 198 467 478 10.1007/s00213-008-1076-0
27. TUC Järbe C Li Q Liu A Makriyannis 2009 Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog Psychopharmacology (Berl) 203 229 239 10.1007/s00213-008-1199-3
28. AD Khanolkar V Abadji S Lin WAG Hill G Taha K Abouzid Z Meng P Fan A Makriyannis 1996 Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand J Med Chem 39 4515 4519 10.1021/jm960152y 1:CAS:528:DyaK28XmtFyqs7w%3D 8893848 (Pubitemid 26359410)
29. RK Kubena H Barry III 1972 Stimulus characteristics of marihuana components Nature 235 397 398 10.1038/235397a0 1:CAS:528:DyaE38XhsV2ltL4%3D 4551648
30. RJ Lamb TUC Järbe 2001 Effects of fluvoxamine on ethanol-reinforced behavior in the rat J Pharmacol Exp Ther 297 1001 1009 1:CAS:528: DC%2BD3MXjvVShsr4%3D 11356922
31. F Mauler J Mittendorf E Horváth J de Vry 2002 Characterization of the diarylether sulfonylester ()-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4, 4, 4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties J Pharmacol Exp Ther 302 359 368 10.1124/jpet.302.1.359 1:CAS:528:DC%2BD38Xlt1SnsLs%3D 12065738 (Pubitemid 34680459)
32. LR McMahon 2006 Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Δ9-tetrahydrocannabinol J Pharmacol Exp Ther 319 1211 1218 10.1124/jpet.106.107110 1:CAS:528:DC%2BD28Xht1yltLzJ 16943255 (Pubitemid 44776468)
33. LR McMahon 2006 Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Δ9- tetrahydrocannabinol Psychopharmacology (Berl) 188 306 314 10.1007/s00213-006- 0500-6 1:CAS:528:DC%2BD28XpsFWmt7c%3D (Pubitemid 44387458)
34. LR McMahon 2009 Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Δ9-tetrahydrocannabinol Psychopharmacology (Berl) 203 219 228 10.1007/s00213-008-1230-8 1:CAS:528:DC%2BD1MXivFWgt7o%3D
35. 9- tetrahydrocannabinol in C57BL/6J mice Psychopharmacology (Berl) 198 487 495 10.1007/s00213-007-0900-2 1:CAS:528:DC%2BD1cXmsVegu74%3D (Pubitemid 351754667)
36. S Mukhopadhyay AC Howlett 2005 Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions Mol Pharmacol 67 2016 2024 10.1124/mol.104.003558 1:CAS:528:DC%2BD2MXkvFGis74%3D 15749995 (Pubitemid 41007783)
37. National Institutes of Health (1996) Principles of animal laboratory care. National Academy, Washington, D.C
38. M Oz 2006 Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids Pharmacol Ther 111 114 144 10.1016/j.pharmthera.2005. 09.009 1:CAS:528:DC%2BD28XltVektrs%3D 16584786 (Pubitemid 43786201)
39. P Pacher S Batkai G Kunos 2006 The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 389 462 10.1124/pr.58.3.2 1:CAS:528:DC%2BD28XhtVOhtLfO 16968947 (Pubitemid 44394908)
40. A Pério M Rinaldi-Carmona J Maruani F Barth G Le Fur P Soubrié 1996 Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A Behav Pharmacol 7 65 71 10.1097/00008877-199605001-00188 11224395
41. RG Pertwee 2008 Ligands that target cannabinoids receptors in the brain: from THC to anandamide and beyond Addict Biol 13 147 159 10.1111/j.1369-1600. 2008.00108.x 1:CAS:528:DC%2BD1cXnvVOksL4%3D 18482430 (Pubitemid 351698890)
42. Z Saidak K Blake-Palmer DL Hay JK Northup M Glass 2006 Differential activation of G-proteins by mu-opioid receptor agonists Br J Pharmacol 147 671 680 10.1038/sj.bjp.0706661 1:CAS:528:DC%2BD28XisFOntrY%3D 16415903
43. M Solinas LV Panlilio Z Justinova S Yasar SR Goldberg 2006 Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats Nat Protoc 1 1194 1206 10.1038/nprot.2006.167 1:CAS:528:DC%2BD28XhtFOitLrO 17406402
44. M Solinas M Scherma L Fattore J Stroik C Wertheim G Tanda W Fratta SR Goldberg 2007 Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse J Neurosci 27 5615 5620 10.1523/JNEUROSCI.0027-07.2007 1:CAS:528:DC%2BD2sXmsVWns78%3D 17522306 (Pubitemid 350021063)
45. 9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport J Pharmacol Exp Ther 321 370 380 10.1124/jpet.106.114124 1:CAS:528:DC%2BD2sXktVSkt70%3D 17210800 (Pubitemid 46456957)
46. 9-THC in rats: tests with aminoalkylindoles (WIN55, 212-2 and AM678) and ethanol. International Cannabinoid Research Society (ICRS), Burlington
47. GA Thakur SP Nikas C Li A Makriyannis 2005 Structural requirements for cannabinoid receptor probes Handb Exp Pharmacol 168 209 246 10.1007/3-540-26573- 2-7 1:CAS:528:DC%2BD2MXkvFeqsL4%3D 16596776
48. RE Vann CD Cook BR Martin JL Wiley 2007 Cannabimimetic properties of ajulemic acid J Pharmacol Exp Ther 320 678 686 10.1124/jpet.106.111625 1:CAS:528:DC%2BD2sXhs1Wku7o%3D 17105826 (Pubitemid 46147948)
49. 9-tetrahydrocannabinol (THC) in C57BL/6J mice Eur J Pharmacol 615 102 107 10.1016/j.ejphar.2009.05.010 1:CAS:528:DC%2BD1MXnslyks70%3D 19470387
50. MJ Wallace PM Newton T McMahon J Connolly A Huibers J Whistler RO Messing 2009 PKCepsilon regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55, 212-2 Neuropsychopharmacology 34 1733 1742 10.1038/npp.2008.230 1:CAS:528:DC%2BD1MXls12qurY%3D 19158669
51. JL Wiley RL Barrett J Lowe RL Balster BR Martin 1995 Discriminative stimulus effects of CP 55, 940 and structurally dissimilar cannabinoids in rats Neuropharmacology 34 669 676 10.1016/0028-3908(95)00027-4 1:CAS:528: DyaK2MXmvFygu7o%3D 7566504
52. 9-tetrahydrocannabinol in rats and rhesus monkeys J Pharmacol Exp Ther 275 1 6 1:CAS:528: DyaK2MXovVKnt7c%3D 7562536
53. JL Wiley DR Compton D Dai JA Lainton M Phillips JW Huffman BR Martin 1998 Structure-activity relationships of indole- and pyrrole-derived cannabinoids J Pharmacol Exp Ther 285 995 1004 1:CAS:528:DyaK1cXjvFClt7g%3D 9618400
54. 9-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats Exp Clin Psychopharmacol 12 173 179 10.1037/1064-1297.12.3.173 1:CAS:528:DC%2BD2cXntVeksbg%3D 15301634 (Pubitemid 38988713)